1
|
Hadisaputri YE, Nurhaniefah AA, Sukmara S, Zuhrotun A, Hendriani R, Sopyan I. Callyspongia spp.: Secondary Metabolites, Pharmacological Activities, and Mechanisms. Metabolites 2023; 13:metabo13020217. [PMID: 36837836 PMCID: PMC9964934 DOI: 10.3390/metabo13020217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2022] [Revised: 01/27/2023] [Accepted: 01/30/2023] [Indexed: 02/05/2023] Open
Abstract
One of the most widespread biotas in the sea is the sponge. Callyspongia is a sponge genus found in the seas, making it easily available. In this review, the pharmacological activity and mechanism of action of the secondary metabolites of Callyspongia spp. are addressed, which may lead to the development of new drugs and targeted therapeutic approaches. Several scientific databases, such as Google Scholar, PubMed, ResearchGate, Science Direct, Springer Link, and Wiley Online Library, were mined to obtain relevant information. In the 41 articles reviewed, Callyspongia spp. was reported to possess pharmacological activities such as cytotoxicity against cancer cell lines (36%), antifungal (10%), anti-inflammatory (10%), immunomodulatory (10%), antidiabetic and antiobesity (6%), antimicrobial (8%), antioxidant (4%), antineurodegenerative (4%), antihypercholesterolemic (2%), antihypertensive (2%), antiparasitic (2%), antiallergic (2%), antiviral (2%), antiosteoporotic (2%), and antituberculosis (2%) activities. Of these, the antioxidant, antituberculosis, and anti-inflammatory activities of Callyspongia extract were weaker compared with that of the control drugs; however, other activities, particularly cytotoxicity, show promise, and the compounds responsible may be developed into new drugs.
Collapse
Affiliation(s)
- Yuni Elsa Hadisaputri
- Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor 45363, Indonesia
- Correspondence: ; Tel.: +62-22-842-88888
| | - Annida Adha Nurhaniefah
- Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor 45363, Indonesia
| | - Sendi Sukmara
- Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor 45363, Indonesia
| | - Ade Zuhrotun
- Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor 45363, Indonesia
| | - Rini Hendriani
- Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor 45363, Indonesia
| | - Iyan Sopyan
- Departement of Pharmaceutics and Technology of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor 45363, Indonesia
| |
Collapse
|
2
|
Chaudhry GES, Md Akim A, Sung YY, Sifzizul TMT. Cancer and apoptosis: The apoptotic activity of plant and marine natural products and their potential as targeted cancer therapeutics. Front Pharmacol 2022; 13:842376. [PMID: 36034846 PMCID: PMC9399632 DOI: 10.3389/fphar.2022.842376] [Citation(s) in RCA: 22] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Accepted: 07/13/2022] [Indexed: 11/24/2022] Open
Abstract
Cancer is a multifactorial, multi-stage disease, including complex cascades of signaling pathways—the cell growth governed by dysregulated and abrupt cell division. Due to the complexity and multi-regulatory cancer progression, cancer is still a challenging disease to treat and survive. The screening of extracts and fractions from plants and marine species might lead to the discovery of more effective compounds for cancer therapeutics. The isolated compounds and reformed analogs were known as future prospective contenders for anti-cancer chemotherapy. For example, Taxol, a potent mitotic inhibitor discovered from Taxus brevifolia, suppresses cell growth and arrest, induces apoptosis, and inhibits proliferation. Similarly, marine sponges show remarkable tumor chemo preventive and chemotherapeutic potential. However, there is limited research to date. Several plants and marine-derived anti-cancer compounds having the property to induce apoptosis have been approved for clinical trials. The anti-cancer activity kills the cell and slows the growth of cancer cells. Among cell death mechanisms, apoptosis induction is a more profound mechanism of cell death triggered by naturally isolated anti-cancer agents. Evading apoptosis is the major hurdle in killing cancer cells, a mechanism mainly regulated as intrinsic and extrinsic. However, it is possible to modify the apoptosis-resistant phenotype of the cell by altering many of these mechanisms. Various extracts and fractions successfully induce apoptosis, cell-cycle modulation, apoptosis, and anti-proliferative activity. Therefore, there is a pressing need to develop new anti-cancer drugs of natural origins to reduce the effects on normal cells. Here, we’ve emphasized the most critical elements: i) A better understanding of cancer progression and development and its origins, ii) Molecular strategies to inhibit the cell proliferation/Carcino-genesis, iii) Critical regulators of cancer cell proliferation and development, iv) Signaling Pathways in Apoptosis: Potential Targets for targeted therapeutics, v) Why Apoptosis induction is mandatory for effective chemotherapy, vi) Plants extracts/fractions as potential apoptotic inducers, vii) Marine extracts as Apoptotic inducers, viii) Marine isolated Targeted compounds as Apoptotic inducers (FDA Approved/treatment Phase). This study provides a potential therapeutic option for cancer, although more clinical studies are needed to verify its efficacy in cancer chemotherapy.
Collapse
Affiliation(s)
- Gul-e-Saba Chaudhry
- Institute of Marine Biotechnology, Universiti Malaysia Terengganu, Kuala Terengganu, Malaysia
- *Correspondence: Gul-e-Saba Chaudhry, ,
| | - Abdah Md Akim
- Department of Biomedical Sciences, Faculty of Medicine and Health sciences, University of Putra Malaysia, Seri Kembangan, Malaysia
| | - Yeong Yik Sung
- Institute of Marine Biotechnology, Universiti Malaysia Terengganu, Kuala Terengganu, Malaysia
| | | |
Collapse
|
3
|
Karthikeyan A, Joseph A, Nair BG. Promising bioactive compounds from the marine environment and their potential effects on various diseases. J Genet Eng Biotechnol 2022; 20:14. [PMID: 35080679 PMCID: PMC8790952 DOI: 10.1186/s43141-021-00290-4] [Citation(s) in RCA: 67] [Impact Index Per Article: 33.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2021] [Accepted: 12/17/2021] [Indexed: 12/30/2022]
Abstract
Background The marine environment hosts a wide variety of species that have evolved to live in harsh and challenging conditions. Marine organisms are the focus of interest due to their capacity to produce biotechnologically useful compounds. They are promising biocatalysts for new and sustainable industrial processes because of their resistance to temperature, pH, salt, and contaminants, representing an opportunity for several biotechnological applications. Encouraged by the extensive and richness of the marine environment, marine organisms’ role in developing new therapeutic benefits is heading as an arable field. Main body of the abstract There is currently much interest in biologically active compounds derived from natural resources, especially compounds that can efficiently act on molecular targets, which are involved in various diseases. Studies are focused on bacteria and fungi, isolated from sediments, seawater, fish, algae, and most marine invertebrates such as sponges, mollusks, tunicates, coelenterates, and crustaceans. In addition to marine macro-organisms, such as sponges, algae, or corals, marine bacteria and fungi have been shown to produce novel secondary metabolites (SMs) with specific and intricate chemical structures that may hold the key to the production of novel drugs or leads. The marine environment is known as a rich source of chemical structures with numerous beneficial health effects. Presently, several lines of studies have provided insight into biological activities and neuroprotective effects of marine algae, including antioxidant, anti-neuroinflammatory, cholinesterase inhibitory activity, and neuronal death inhibition. Conclusion The application of marine-derived bioactive compounds has gained importance because of their therapeutic uses in several diseases. Marine natural products (MNPs) display various pharmaceutically significant bioactivities, including antibiotic, antiviral, neurodegenerative, anticancer, or anti-inflammatory properties. The present review focuses on the importance of critical marine bioactive compounds and their role in different diseases and highlights their possible contribution to humanity.
Collapse
Affiliation(s)
- Akash Karthikeyan
- School of Biotechnology, National Institute of Technology Calicut, Calicut, Kerala, India
| | - Abey Joseph
- School of Biotechnology, National Institute of Technology Calicut, Calicut, Kerala, India
| | - Baiju G Nair
- School of Biotechnology, National Institute of Technology Calicut, Calicut, Kerala, India. .,Nanomedical Engineering Laboratory, Riken, Wako, Saitama, Japan.
| |
Collapse
|
4
|
de Sousa LHN, de Araújo RD, Sousa-Fontoura D, Menezes FG, Araújo RM. Metabolities from Marine Sponges of the Genus Callyspongia: Occurrence, Biological Activity, and NMR Data. Mar Drugs 2021; 19:663. [PMID: 34940662 PMCID: PMC8706505 DOI: 10.3390/md19120663] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2021] [Revised: 11/17/2021] [Accepted: 11/23/2021] [Indexed: 01/03/2023] Open
Abstract
The genus Callyspongia (Callyspongiidae) encompasses a group of demosponges including 261 described species, of which approximately 180 have been accepted after taxonomic reviews. The marine organisms of Callyspongia are distributed in tropical ecosystems, especially in the central and western Pacific, but also in the regions of the Indian, the West Atlantic, and the East Pacific Oceans. The reason for the interest in the genus Callyspongia is related to its potential production of bioactive compounds. In this review, we group the chemical information about the metabolites isolated from the genus Callyspongia, as well as studies of the biological activity of these compounds. Through NMR data, 212 metabolites were identified from genus Callyspongia (15 species and Callyspongia sp.), belonging to classes such as polyacetylenes, terpenoids, steroids, alkaloids, polyketides, simple phenols, phenylpropanoids, nucleosides, cyclic peptides, and cyclic depsipeptides. A total of 109 molecules have been reported with bioactive activity, mainly cytotoxic and antimicrobial (antibacterial and antifungal) action. Thus, we conclude that polyacetylenes, terpenoids and steroids correspond to the largest classes of compounds of the genus, and that future research involving the anticancer action of the species' bioactive metabolites may become relevant.
Collapse
Affiliation(s)
- Lucas Hilário Nogueira de Sousa
- Instituto de Química, Universidade Federal do Rio Grande do Norte, Natal 59078-970, Brazil; (L.H.N.d.S.); (R.D.d.A.); (F.G.M.)
| | - Rusceli Diego de Araújo
- Instituto de Química, Universidade Federal do Rio Grande do Norte, Natal 59078-970, Brazil; (L.H.N.d.S.); (R.D.d.A.); (F.G.M.)
| | | | - Fabrício Gava Menezes
- Instituto de Química, Universidade Federal do Rio Grande do Norte, Natal 59078-970, Brazil; (L.H.N.d.S.); (R.D.d.A.); (F.G.M.)
| | - Renata Mendonça Araújo
- Instituto de Química, Universidade Federal do Rio Grande do Norte, Natal 59078-970, Brazil; (L.H.N.d.S.); (R.D.d.A.); (F.G.M.)
| |
Collapse
|
5
|
Noji M, Yoneyama T, Nishihama K, Elshamy AI, Hashimoto T, Umeyama A. Pentacyclic triterpenoids, fuscotorunones A and B, with ε-caprolactone in ring E from Fuscoporia torulosa. PHYTOCHEMISTRY 2021; 187:112748. [PMID: 33839519 DOI: 10.1016/j.phytochem.2021.112748] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Revised: 03/18/2021] [Accepted: 03/19/2021] [Indexed: 06/12/2023]
Abstract
Fuscoporia torulosa (Pers.) (Hymenochaetaceae) is a mushroom forming woody fruiting body on living or dead trees. Two curious pentacyclic triterpenoids, fuscotorunones A and B, each of which has a unique ε-caprolactone in ring E, were isolated from the fruiting bodies of F. torulosa. The structures of fuscotorunones A and B were elucidated using MS analyses, IR spectrum and extensive 2D-homo and heteronuclear NMR data interpretation. Furthermore, a predicted biosynthetic pathway from 2,3-oxidosqualene to fuscotorunones A and B in F. torulosa is proposed.
Collapse
Affiliation(s)
- Masaaki Noji
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima, 7708514, Japan.
| | - Tatsuro Yoneyama
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima, 7708514, Japan
| | - Kouichi Nishihama
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima, 7708514, Japan
| | - Abdelsamed I Elshamy
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima, 7708514, Japan; Chemistry of Natural Compounds Department, National Research Centre, 33 El Bohouth St., Dokki, Giza, 12622, Egypt
| | - Toshihiro Hashimoto
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima, 7708514, Japan
| | - Akemi Umeyama
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima, 7708514, Japan
| |
Collapse
|
6
|
Marine Sponge Natural Products with Anticancer Potential: An Updated Review. Mar Drugs 2017; 15:md15100310. [PMID: 29027954 PMCID: PMC5666418 DOI: 10.3390/md15100310] [Citation(s) in RCA: 91] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2017] [Revised: 09/28/2017] [Accepted: 10/09/2017] [Indexed: 12/11/2022] Open
Abstract
Despite the huge investment into research and the significant effort and advances made in the search for new anticancer drugs in recent decades, cancer cure and treatment continue to be a formidable challenge. Many sources, including plants, animals, and minerals, have been explored in the oncological field because of the possibility of identifying novel molecular therapeutics. Marine sponges are a prolific source of secondary metabolites, a number of which showed intriguing tumor chemopreventive and chemotherapeutic properties. Recently, Food and Drug Administration-approved drugs derived from marine sponges have been shown to reduce metastatic breast cancer, malignant lymphoma, and Hodgkin's disease. The chemopreventive and potential anticancer activity of marine sponge-derived compounds could be explained by multiple cellular and molecular mechanisms, including DNA protection, cell-cycle modulation, apoptosis, and anti-inflammatory activities as well as their ability to chemosensitize cancer cells to traditional antiblastic chemotherapy. The present article aims to depict the multiple mechanisms involved in the chemopreventive and therapeutic effects of marine sponges and critically explore the limitations and challenges associated with the development of marine sponge-based anticancer strategy.
Collapse
|
7
|
Swapana N, Noji M, Nishiuma R, Izumi M, Imagawa H, Kasai Y, Okamoto Y, Iseki K, Singh CB, Asakawa Y, Umeyama A. A New Diphenyl Ether Glycoside from Xylosma longifolium Collected from North-East India. Nat Prod Commun 2017. [DOI: 10.1177/1934578x1701200832] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
A new diphenyl ether glycoside, xylosmaloside (1), was isolated from the MeOH extract of Xylosma longifolium Clos. The structure of xylosmaloside (1) was elucidated using MS analyses, extensive 2D-homo and heteronuclear NMR data interpretation and the chemical conversions. Xylosmaloside (1) showed stronger antioxidant activity than ascorbic acid.
Collapse
Affiliation(s)
- Ningombam Swapana
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
- S. Kula Women's College, Nambol-795134, Manipur, India
| | - Masaaki Noji
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Rina Nishiuma
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Masahiro Izumi
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Hiroshi Imagawa
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Yuusuke Kasai
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Yasuko Okamoto
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Kanako Iseki
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | | | - Yoshinori Asakawa
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Akemi Umeyama
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| |
Collapse
|
8
|
Mioso R, Marante FJT, Bezerra RDS, Borges FVP, Santos BVDO, Laguna IHBD. Cytotoxic Compounds Derived from Marine Sponges. A Review (2010-2012). Molecules 2017; 22:E208. [PMID: 28134844 PMCID: PMC6155849 DOI: 10.3390/molecules22020208] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2016] [Revised: 01/11/2017] [Accepted: 01/17/2017] [Indexed: 12/20/2022] Open
Abstract
Abstract: This extensive review covers research published between 2010 and 2012 regarding new compounds derived from marine sponges, including 62 species from 60 genera belonging to 33 families and 13 orders of the Demospongia class (Porifera). The emphasis is on the cytotoxic activity that bioactive metabolites from sponges may have on cancer cell lines. At least 197 novel chemical structures from 337 compounds isolated have been found to support this work. Details on the source and taxonomy of the sponges, their geographical occurrence, and a range of chemical structures are presented. The compounds discovered from the reviewed marine sponges fall into mainly four chemical classes: terpenoids (41.9%), alkaloids (26.2%), macrolides (8.9%) and peptides (6.3%) which, along with polyketides, sterols, and others show a range of biological activities. The key sponge orders studied in the reviewed research were Dictyoceratida, Haplosclerida, Tetractinellida, Poecilosclerida, and Agelasida. Petrosia, Haliclona (Haplosclerida), Rhabdastrella (Tetractinellida), Coscinoderma and Hyppospongia (Dictyioceratida), were found to be the most promising genera because of their capacity for producing new bioactive compounds. Several of the new compounds and their synthetic analogues have shown in vitro cytotoxic and pro-apoptotic activities against various tumor/cancer cell lines, and some of them will undergo further in vivo evaluation.
Collapse
Affiliation(s)
- Roberto Mioso
- Laboratory of Enzymology - LABENZ, Department of Biochemistry, Federal University of Pernambuco, Recife 50670-901, Pernambuco, Brazil.
| | - Francisco J Toledo Marante
- Department of Chemistry, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria 35017, Spain.
| | - Ranilson de Souza Bezerra
- Laboratory of Enzymology - LABENZ, Department of Biochemistry, Federal University of Pernambuco, Recife 50670-901, Pernambuco, Brazil.
| | - Flávio Valadares Pereira Borges
- Post-Graduation Program in Natural Products and Synthetic Bioactives, Federal University of Paraíba, João Pessoa 58051-970, Paraíba, Brazil.
| | - Bárbara V de Oliveira Santos
- Post-Graduation Program in Development and Technological Innovation in Medicines, Department of Pharmaceutical Sciences, Federal University of Paraiba, João Pessoa 58051-900, Paraíba, Brazil.
| | | |
Collapse
|
9
|
Nishio A, Mikami H, Imagawa H, Hashimoto T, Tanaka M, Ito T, Iguchi M, Iseki K, Noji M, Umeyama A. Two Novel Diphenolic Metabolites from the Inedible Mushroom Thelephora palmata. Nat Prod Commun 2016. [DOI: 10.1177/1934578x1601100828] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
During the search for bioactive secondary metabolites, thelepalmatins A and B (1 and 2) were isolated from the fresh fruiting bodies of Thelephora palmata, together with four known compounds (3-6). Their structures were elucidated using MS analyses, and extensive 2D-heteronuclear NMR data interpretation. Compounds 3, 4 and 6 showed antimicrobial activities against Staphylococcus aureus and Bacillus subtilis with MIC values of 21.7-70.4 μM.
Collapse
Affiliation(s)
- Ayako Nishio
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Haruka Mikami
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Hiroshi Imagawa
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Toshihiro Hashimoto
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Masami Tanaka
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Takuya Ito
- Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan
| | - Miki Iguchi
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Kanako Iseki
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Masaaki Noji
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Akemi Umeyama
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| |
Collapse
|
10
|
Kokudo N, Okazoe M, Takahashi J, Iseki K, Yoshikawa K, Imagawa H, Hashimoto T, Noji M, Umeyama A. Six New Lanostane Triterpenoids from the Fruiting Body of Tyromyces Sambuceus and Antiproliferative Activity. Nat Prod Commun 2016. [DOI: 10.1177/1934578x1601100208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
During the search for secondary metabolites with antiproliferative activity, six new lanostane triterpenoids, tyrosamic acids A-F (1–6) together with ten known compounds (7–16), were isolated from the fruiting body of Tyromyces sambuceus. Their structures were elucidated using MS analyses, extensive 2D-heteronuclear NMR data interpretation and the structure of 3 was further confirmed by single-crystal X-ray data analyses. All lanostane triterpenoids (1–16) possesses a carboxy group at C-20 position and their strength of antiproliferative activity was affected by the presence or absence of a hydroxy group at C-15 position and at the side chain. Four of the compounds (1, 6, 10, 14) showed antiproliferative activities against human cancer cell lines with IC50 values of 16.8–48.3 μM (HL-60).
Collapse
Affiliation(s)
- Naoki Kokudo
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Mina Okazoe
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Joji Takahashi
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Kanako Iseki
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Kazuko Yoshikawa
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Hirosi Imagawa
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Toshihiro Hashimoto
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Masaaki Noji
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| | - Akemi Umeyama
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan
| |
Collapse
|
11
|
Zhou ZF, Menna M, Cai YS, Guo YW. Polyacetylenes of marine origin: chemistry and bioactivity. Chem Rev 2014; 115:1543-96. [PMID: 25525670 DOI: 10.1021/cr4006507] [Citation(s) in RCA: 117] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Affiliation(s)
- Zhen-Fang Zhou
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Zu Chong Zhi Road 555, Shanghai 201203, China
| | | | | | | |
Collapse
|
12
|
|
13
|
Essack M, Bajic VB, Archer JA. Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment. Mar Drugs 2011; 9:1580-1606. [PMID: 22131960 PMCID: PMC3225937 DOI: 10.3390/md9091580] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2011] [Revised: 08/31/2011] [Accepted: 09/07/2011] [Indexed: 01/23/2023] Open
Abstract
Despite intense efforts to develop non-cytotoxic anticancer treatments, effective agents are still not available. Therefore, novel apoptosis-inducing drug leads that may be developed into effective targeted cancer therapies are of interest to the cancer research community. Targeted cancer therapies affect specific aberrant apoptotic pathways that characterize different cancer types and, for this reason, it is a more desirable type of therapy than chemotherapy or radiotherapy, as it is less harmful to normal cells. In this regard, marine sponge derived metabolites that induce apoptosis continue to be a promising source of new drug leads for cancer treatments. A PubMed query from 01/01/2005 to 31/01/2011 combined with hand-curation of the retrieved articles allowed for the identification of 39 recently confirmed apoptosis-inducing anticancer lead compounds isolated from the marine sponge that are selectively discussed in this review.
Collapse
Affiliation(s)
| | | | - John A.C. Archer
- Author to whom correspondence should be addressed; E-Mail: ; Tel.: +966-544-700-701; Fax: +966-(2)-802-0127
| |
Collapse
|
14
|
Ibrahim SRM, Min CC, Teuscher F, Ebel R, Kakoschke C, Lin W, Wray V, Edrada-Ebel R, Proksch P. Callyaerins A-F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa. Bioorg Med Chem 2010; 18:4947-56. [PMID: 20599387 DOI: 10.1016/j.bmc.2010.06.012] [Citation(s) in RCA: 65] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2010] [Revised: 05/26/2010] [Accepted: 06/04/2010] [Indexed: 11/20/2022]
Abstract
Bioassay guided fractionation of the EtOAc fraction of the sponge Callyspongia aerizusa yielded seven new cytotoxic cyclic peptides callyaerins A-F (1-6) and H (8). Their structures were determined using extensive 1D (1H, 13C and DEPT) and 2D (COSY, HMQC, HMBC, TOCSY, and ROESY) NMR and mass spectral (ESI and HRESI-TOF) data. All compounds were cyclic peptides containing ring systems of 5-9 amino acids and side chains of 2-5 amino acids in length. An unusual (Z)-2,3-diaminoacrylic acid unit provided the template for ring closure and afforded the linkage to the peptidic side chain which was always initiated with a proline moiety. All peptides contained three or more proline residues and the remaining residues were predominantly hydrophobic residues with all amino acids present in the l form. Callyaerins A-F (1-6) and H (8) showed biological activity in antibacterial assays and in various cytotoxicity assays employing different tumour cell-lines (L5178Y, HeLa, and PC12). Callyaerins E (5) and H (8) exhibited strong activity against the L5178Y cell line with ED50 values of 0.39 and 0.48 microM, respectively. On the other hand, callyaerin A (1) showed strong inhibitory properties towards C. albicans.
Collapse
Affiliation(s)
- Sabrin R M Ibrahim
- Institut für Pharmazeutische Biologie und Biotechnologie, Heinrich-Heine-Universität, Geb. 26.23, Universitätsstrasse 1, D-40225 Düsseldorf, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Takei M, Umeyama A, Shoji N, Hashimoto T. Polyacetylenediols regulate the function of human monocyte-derived dendritic cells. Int Immunopharmacol 2010; 10:913-21. [PMID: 20493278 DOI: 10.1016/j.intimp.2010.05.002] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2009] [Revised: 03/13/2010] [Accepted: 05/10/2010] [Indexed: 11/29/2022]
Abstract
Callyspongidiol and 14,15-dihydrosiphonodiol are Polyacetylenediols isolated from marine sponges and are pharmacologically active substances. Dendritic cells (DC) play an important role in the initiation and regulation of immune response. DC have a key influence in the differentiation of naïve T cells into Th1, Th2 or Th17 effector cells. We demonstrated that callyspongidiol and 14,15-dihydrosiphonodiol activate human DC as documented by phenotypic and functional maturation, and altered cytokine production. Up regulation of cell surface expression of CD1a, CD80, CD83, CD86, HLA-DR and CCR7 was observed following DC treatment with callyspongidiol and 14,15-dihydrosiphonodiol. The production of IL-10 by callyspongidiol-primed DC after stimulation with CD40-L was higher than that of LPS- or 14,15-dihydrosiphonodiol-primed DC. Naïve T cells co-cultured with allogeneic 14,15-dihydrosiphonodiol-primed DC at 1:5 DC/T cell ratio turned into typical Th1 cells depending on IL-12 secretion and independent on TLR2 or TLR4. In contrast, callyspongidiol-primed DC co-cultured with naïve T cells secreted IL-4 and IL-10, but had little effect on IFN-gamma. Callyspongidiol-primed DC induced the development of Th2 cells via the inhibition of IL-12p70 and the enhancement of IL-10. Polyacetylenediols-primed DC expressed the chemokine receptor CCR7 and had a high migration to CCL19. These results suggested that some Polyacetylenediols modulate human DC function in a fashion that favors Th1/Th2 cell polarization or IL-10 producing T cells, and might have implication in tumor or in autoimmune diseases.
Collapse
Affiliation(s)
- Masao Takei
- Division of Cellular Allergology, Research Center Borstel, Parkallee 22, D-23845 Borstel, Germany.
| | | | | | | |
Collapse
|